N-myc gene copy numbers and transcription rates are similar in N (neuroblastic, tumorigenic) and S (nonneuronal, non-tumorigenic) neuroblastoma cells with chromosomally integrated ampli®ed N-myc genes. However, N cells show signi®cantly higher N-myc mRNA levels than S cells. Therefore, post-transcriptional control of N-myc gene expression must dier between these cell types. Since no dierences in N-myc mRNA half-life were found between N and S cells from two cell lines, steady-state levels of N-myc pre-mRNA processing intermediates were analysed. Results suggest that the dierences in N-myc expression arise primarily at the nuclear post-transcriptional level. The neuronal-speci®c RNA-binding Hu proteins are present in cytoplasmic and nuclear fractions of N cells and one of them, HuD, binds speci®cally to both exonic and intronic N-myc RNA sequences. In sense and antisense HuD-transfected N cells, there are coordinate changes in HuD and N-myc expression levels. Thus, we propose that HuD plays a role in the nuclear processing/stability of N-myc premRNA in N-type neuroblastoma cells.
Introduction
Neuroblastoma (NB), a childhood cancer, arises from embryonic neural crest cells (Crist and Kun, 1984) . Cell lines derived from NB tumors comprise morphologically and biochemically distinct cell types that resemble precursors of neuronal and non-neuronal neural crest cell derivatives (Ciccarone et al., 1989; Rettig et al., 1987; Ross et al., 1995) . Neuroblastic (N-type) cells have characteristics of sympathoadrenal neuroblasts, whereas substrate-adherent (S-type) cells resemble immature Schwann/glial/melanoblastic cells.
One-third of NB tumors and most cell lines derived from this tumor exhibit ampli®cation of the N-myc proto-oncogene (Brodeur et al., 1981; Kohl et al., 1983) . Experimental and clinical evidence suggests that this gene plays a pivotal role in malignancy (Brodeur et al., 1984; Seeger et al., 1985) . Earlier studies had indicated that, in culture, malignant potential and Nmyc expression level are determined, at least in part, by cell phenotype. In cell lines that amplify the N-myc gene, N cells have abundant steady-state levels of Nmyc mRNA and protein and are tumorigenic, whereas S cells exhibit reduced N-myc expression levels and are not tumorigenic (Spengler et al., 1997) . When ampli®ed N-myc genes are present as double minute chromosomes, the lower N-myc mRNA and protein levels in S cells are due to gene loss. However, N and S cells derived from parental cell lines with chromosomally integrated N-myc amplicons (e.g., LA-N-1 and SK-N-BE(2)) have similar N-myc gene copy numbers (160 vs 118 and 134 vs 141 per haploid genome, respectively), but 3 ± 5-fold dierences in N-myc mRNA and protein.
Thus, in some of the most malignant cells, N-myc expression appears to be regulated at the RNA level.
One common mechanism whereby mRNA levels can be altered is transcriptional regulation. However, transcription rates for N-myc genes in N and S cells are commensurate with gene copy numbers and therefore cannot account for the observed 3.8-and 4.9-fold lower N-myc mRNA steady-state levels in S cells (Spengler et al., 1997) . These ®ndings support previous reports that the expression of N-myc, unlike that of c-myc or L-myc, is not regulated by block to transcriptional elongation Krystal et al., 1988) . N-myc gene transcription rates are similar not only in tumor cell lines such as SK-N-MC (neuroepithelioma), G401 (Wilms' tumor), and HeLa (carcinoid) cells (HeLa cells do not accumulate detectable levels of cytoplasmic N-myc mRNA), but also in many normal adult mouse tissues (Babiss and Friedman, 1990) . The dierent N-myc mRNA levels in such cell lines and tissues have been demonstrated to be a result of cell-speci®c dierences in the post-transcriptional control of the N-myc gene expression (Babiss and Friedman, 1990) . Thus, dierences in N-myc expression between N and S NB cells with chromosomally integrated ampli®ed N-myc genes most likely arise at the post-transcriptional level. Post-transcriptional control can take place in the nucleus and/or cytoplasm and N-myc mRNA has previously been postulated to be stabilized in the cytoplasm of N cells by two RNA-binding proteins, HuD and Hel-N1 .
The three related Hu proteins ± HuD, Hel-N1, and HuC/Ple21 (hereafter referred to as HuC) ± are antigens recognized by antibodies in sera from patients with paraneoplastic encephalomyelitis (PEM) and paraneoplastic sensory neuropathy (PSN), neurological syndromes associated with neuronal/neuroendocrine cancers such as small cell lung cancer (SCLC), NB, and others (Dalmau et al., , 1992 . HuD, HuC, and Hel-N1 show 82 ± 90% sequence homology (King et al., 1994; Sakai et al., 1993; Szabo et al., 1991) . In addition, they show an *54% homology to the Drosophila melanogaster RNA-binding proteins Sex-lethal and ELAV (King et al., 1994; Szabo et al., 1991) , which participate in alternative splicing (Baker, 1989; Koushika et al., 1996) . A role for the Hu proteins in neuronal dierentiation and survival is implied by their expression pattern in avian neural crest cells (Marusich and Weston, 1992; Marusich et al., 1994; Wakamatsu and Weston, 1997) and mouse embryos (Okano and Darnell, 1997) , as well as in neurons of adult human central and peripheral nervous systems . The Hu proteins have three highly homologous RNA-recognition motifs, the second and third separated by a less conserved stringer region (Szabo et al., 1991) . HuD and Hel-N1 bind in vitro to AU-rich elements in the 3'-untranslated regions (3'-UTR) of mRNAs Gao et al., 1994; Jain et al., 1997; King et al., 1994; Levine et al., 1993; Liu et al., 1995) . Other proteins binding AUrich sequences have been shown to destabilize mRNAs encoding growth-regulatory proteins (Brawerman, 1989; Sachs, 1993; Shaw and Kamen, 1986) , participate in the regulation of RNA splicing (McCullough and Schuler, 1993; Singh et al., 1995) , and transport messages from the nucleus (Muller et al., 1992) . This suggests that one or several of the Hu proteins might participate in nuclear processing or transport of N-myc RNA. However, the precise role of the Hu proteins is still unclear.
The present study was undertaken to de®ne (i) the mechanism of cell-speci®c regulation of N-myc expression in N and S NB cells and (ii) the possible role of HuD and/or Hel-N1 in the expression of the Nmyc proto-oncogene. Our results strongly suggest that HuD is involved in the nuclear processing and/or stabilization of N-myc pre-mRNA species in N cells.
Results
Expression and cellular localization of Hu antigens in NB cell variants N and S sublines isolated from two N-myc-ampli®ed cell lines with chromosomally integrated N-myc genes (SK-N-BE(2) and LA-N-1) and from the non-ampli®ed SK-N-SH cell line (Spengler et al., 1997) were examined for Hu protein expression using sera from patients with PSN/PEM. As shown in Figure 1a , N cells (SH-SY5Y, SK-N-BE(2)n, LA1-55n) are Huimmunoreactive whereas their S cell counterparts (SH-EP1, SK-N-BE(2)s, LA1-5s) are not. Since these antisera recognize all three Hu proteins (Hel-N1, HuD, and HuC) (Manley et al., 1995) , Northern blot analysis was performed to determine which members of the Hu antigen family are expressed in N cells. Probes speci®c for HuD, HuC, and Hel-N1 were derived from the stringer regions, which are less conserved among these homologous proteins (Good, 1995; Szabo et al., 1991) . As shown in Figure 1b , N cells express all three Hu mRNAs, at dierent levels. In general, Hu mRNAs were not detected in S cells (Figure 1b ). Subsequent hybridization with an N-myc probe con®rmed previous ®ndings that N-myc expression levels are greater in N than in S cells (Spengler et al., 1997) . It is apparent from these analyses that expression of the Hu antigens is a function of dierentiation lineage rather than of Nmyc gene ampli®cation, since non-ampli®ed N-type SH-SY5Y cells are Hu-positive whereas N-myc ampli®ed S-type LA1-5s cells, which do express some N-myc mRNA and protein, are Hu-negative.
Hu proteins have been previously localized to cytosolic polysomal fractions of medulloblastoma and N-type NB cells Gao and Keene, 1996) or to nuclei of SCLC and NB tumor cells and of central and peripheral neurons (Dalmau et al., 1992; Gao and Keene, 1996; Hormigo and Lieberman, 1994; Kostyk et al., 1996; Tora et al., 1997) . Subcellular fractionation of LA1-55n cells showed that Hu proteins are present in both nuclear and cytoplasmic fractions (Table 1) . Intercompartmental contamination, determined with protein markers speci®c for nuclear (lamins) and cytoplasmic (neuro®lament 150 and secretogranin II) fractions, was minimal. Presence of Hu proteins in both nucleus and cytoplasm of N cells was con®rmed by immunocytochemistry (data not shown).
Half-life of N-myc mRNA in N and S NB cells HuD and Hel-N1 have been proposed to stabilize Nmyc mRNA in the cytoplasm of N-type NB cells by binding to the 3'-UTR . Therefore, we determined the half-life of N-myc mRNA in N and S sublines derived from the LA-N-1 cell line. N-myc mRNA half-life is similar in LA1-55n and LA1-5s cells (*38 min) (Figure 2 ), con®rming our previous ®nding of similar (*33 min) half-lives in the N and S cells derived from the SK-N-BE(2) cell line (Spengler et al., 1997) . Thus, reduced cytoplasmic 
N-myc pre-mRNA steady-state levels in N and S cells
To test whether nuclear post-transcriptional regulation may account for the dierences in N-myc mRNA levels in N and S cells, we analysed the steady-state levels of N-myc pre-mRNA processing intermediates in poly(A) + and total nuclear RNA fractions from LA1-55n and LA1-5s cells by Northern blot analysis. The N-myc gene is composed of three exons and two introns (Stanton et al., 1986) . To detect all possible pre-mRNA processing intermediates, Northern blots were hybridized with probes to both introns and to exon 3. In poly(A) + RNA fractions from both N and S cells, all three probes detected the previously reported (Krystal et al., 1990) cleaved and polyadenylated 6.6 kb N-myc transcript ( Figure 3) . The 6.6 kb pre-mRNA species could be subsequently processed by splicing of either intron 1, to generate a 5.8 kb RNA splicing intermediate, or intron 2, to generate a 4.2 kb splicing intermediate. Hybridization of the poly(A) + RNA fraction with intron 1 and exon 3 probes con®rmed the existence of a 4.2 kb RNA splicing intermediate ( Figure 3 ) (Krystal et al., 1990) . Hybridization with intron 2 and exon 3 probes identi®ed the second possible splicing intermediate of 5.8 kb ( Figure 3 ). The intron 2 probe also recognized two polyadenylated RNA species of 4.7 and 2.7 kb ( Figure 3 ). However, these species were not labeled by the exon 3 probe and, therefore, they could not give rise to mature 3.2 kb N-myc mRNA. All polyadenylated Nmyc pre-mRNA processing intermediates were also detected in total nuclear RNA fractions (data not shown).
The same polyadenylated N-myc pre-mRNA processing intermediates are present in both N and S cells. However, there are dierences in amount between the two NB cell variants (Table 2) , and these dierences increase in magnitude with extent of processing. N-myc transcription rate is approximately 1.4-fold greater in LA1-55n than in LA1-5s cells, consistent with dierences in gene copy numbers (160 and 118, respectively) (Spengler et al., 1997) . The 2.3-fold dierence between N and S cells in the steady-state levels of the polyadenylated, non-spliced 6.6 kb N-myc pre-mRNA and the 3.4-fold dierence in the steadystate levels of the 4.2 kb N-myc splicing intermediate could result from altered stability of these RNA species and/or processing eciency. + RNA. Probes to N-myc exon 3 and introns 1 and 2 were used to identify all possible polyadenylated N-myc pre-mRNA processing intermediates. To visualize the much less abundant pre-mRNA species, blots were overloaded and overexposed with respect to the abundant mature 3.2 kb RNA. Therefore, in this Figure, the amount of the 3.2 kb mature N-myc mRNA labeled with the exon 3 probe is outside the quanti®able range. The signal for g-actin mRNA was used to normalize for loading dierences 3.8 a Ratios of N-myc gene copy numbers, transcription rates and levels of cytoplasmic mRNA in LA1-55n and LA1-5s were recently reported by Spengler et al. (1997). b Ratio (mean+s.e.m.) of steadystate levels for each poly(A) + pre-mRNA in paired N and S cells was calculated from three independent preparations. The optical density of the signal for each N-myc RNA species was normalized against that of g-actin mRNA
Binding of Hu proteins to exonic and intronic sequences of N-myc RNA HuD and Hel-N1 bind short uridine (U)-rich sequences within the N-myc 3'-UTR . However, in addition to U-rich segments, Sex-lethal (a Drosophila RNA-binding protein homologous to the Hu proteins) also binds non-U-rich sequences associated with RNA secondary structure (Wang et al., 1997) . Therefore, we examined the binding of Hu proteins to long (400 ± 870 nucleotides (nt)) N-myc transcripts by gel mobility shift assays (GMSA). In these assays, RNA bound by recombinant protein in bacterial lysates migrates more slowly than the free probe through a non-denaturing gel. If no binding occurs, the RNA probe is degraded by endogenous bacterial ribonucleases. We used an 873 nt transcript which contains almost the full length N-myc 3'-UTR (data not shown) as well as two shorter transcripts (491 nt and 399 nt) representing the ®rst and second halves of the same region (Figure 4 ). Only HuDcontaining lysate bound and shifted the N-myc 3'-UTR probes. HuC-containing lysate showed weak binding to the 3' half of the N-myc 3'-UTR (Figure 4b, lane 4) . However, competition experiments revealed that this binding was not speci®c (data not shown).
The speci®city of HuD binding to N-myc RNA was assessed by two dierent methods. In competition experiments, addition of increasing amounts of unlabeled N-myc 3'-UTR transcript proportionally decreased the gel mobility shift of the labeled transcript and the intensity of the signal (Figure 5a ).
Second, in titration experiments, addition of increasing amounts of HuD-containing bacterial lysate to the RNA probe resulted in increasing retardation of mobility of the probe (Figure 5b ). Thus, both assays suggest that the binding of HuD to the N-myc 3'-UTR is speci®c.
The ability of HuD to bind two additional nonneuronal RNA 3'-UTRs derived from the carcinoembryonic antigen (CEA) and the a-actinin (ACTN4) genes was also tested. HuD did not bind speci®cally to either 3'-UTR.
In addition to the binding assays with N-myc exonic (3'-UTR) sequences, we assessed the ability of Hu proteins to bind intronic N-myc RNA elements. We reasoned that the Hu proteins may regulate nuclear Nmyc RNA processing based on (i) the dierent steadystate levels of N-myc pre-mRNA processing intermediates in N and S cells, (ii) the presence of Hu immunoreactivity in nuclei of N cells, and (iii) the homology of the Hu proteins to splicing factors Sexlethal and ELAV. GMSA revealed that only HuD of the three Hu proteins binds N-myc intron 1 sequences ( Figure 6 ). The speci®city of HuD binding to intron 1 sequences was con®rmed by competition and titration assays (data not shown).
Transfections of NB cells with sense and antisense HuD constructs
To test our hypothesis that HuD regulates N-myc mRNA expression in vivo, we transiently transfected LA1-55n cells, which constitutively express HuD (Figure 1) , with a HuD expression construct (pcDNA3HuD) containing a 1.7 kb HuD cDNA. In four independent, transiently-transfected LA1-55n populations, Hu protein amount increased significantly (19.5+2.5%) compared to vector-transfected controls. These same cells showed a 47.7+5.5% increase in amount of N-myc protein. Resulting Hu and N-myc protein levels from two independent populations 24 h after transfection are illustrated in Figure 7 . Stable HuD sense transfectant clones were isolated to determine amounts of N-myc splice intermediates. However, although the exogenous 1.7 kb HuD transcript continued to be stably expressed in the transfectants, endogenous HuD mRNA levels were down-regulated within 30 days after transfection and N-myc protein levels returned to normal.
In related experiments, two N-type sublines, LA1-55n and BE(2)-M17 (a twice-cloned subline of SK-N-BE(2)), were stably transfected with a construct containing a 197 nt HuD cDNA sequence in an antisense orientation. The expression of antisense HuD mRNA was con®rmed by RT ± PCR analysis (data not shown). Initial Northern blot analysis of the slowly growing antisense HuD-transfectants revealed that the steady-state HuD mRNA levels in 6 LA1-55n and 7 BE(2)-M17 antisense clones were approximately threefold lower than those in 1 LA1-55n and 3 BE(2)-M17 vector-transfected controls. The inhibition was speci®c for HuD, since Hel-N1 and HuC mRNA levels were unchanged. Signi®cantly, the decrease in HuD mRNA level was accompanied by a proportional decrease in N-myc mRNA (Figure 8 ). Continued cultivation of the antisense HuD-transfected clones was accompanied by a gradual acquisition of a more Slike phenotype, making further analysis of the transfectants uninformative.
Discussion

Expression of Hu proteins in NB cell variants
Our ®nding, that the three Hu genes are expressed in N-type NB cells, is in agreement with previous ®ndings that HuD and Hel-N1 are expressed in N-type NB cells and that all three genes are expressed in normal human brain (Manley et al., 1995) . The co-expression of HuD and N-myc in tumor cells may re¯ect their normal co-expression in neuronal tissues during embryonic development, an idea suggested by studies showing the presence of HuD mRNA in neurons of the intermediate zone in developing mouse brain and of elevated N-myc mRNA levels in identical cells in developing human embryos (Hirvonen, 1989; Okano and Darnell, 1997) . The absence of Hu proteins in S cells, consistent with the proposed identi®cation of these cells as neural crest-derived non-neuronal cells, and the presence of Hu proteins in both non-ampli®ed and ampli®ed neuroblastic cells (SH-SY5Y, LA1-55n, and SK-N-BE(2)n, Figure 1a ) indicate that expression of Hu proteins is a characteristic of the neuronal differentiation lineage. The fact that Hu-negative S cells with ampli®ed N-myc genes (LA1-5s cells, Figure 1b) express N-myc at detectable levels (1) indicates that N-myc transcripts can be processed to mature mRNA in the absence of HuD, but (2) does not exclude the possibility that HuD may increase the processing eciency and/or the nuclear stability of the N-myc transcripts in cells that express the protein.
Nuclear N-myc RNA intermediates in N-and S-type NB cells N-myc gene transcription is approximately 1.4-fold higher in LA-N-1 N than S cells, consistent with gene copy numbers in these cells (Spengler et al., 1997) and thus cannot be the only cause of the quantitative dierences in N-myc RNA processing intermediates in N vs S cells ( Table 2 ). The 2.3-fold dierence in the steady-state levels of the polyadenylated, non-spliced 6.6 kb N-myc pre-mRNA could result from higher eciency of the cleavage/polyadenylation reaction and/ or higher stability of the nascent or the cleaved, polyadenylated pre-mRNA in N cells. The 3.4-fold dierence in the steady-state levels of the 4.2 kb N-myc splicing intermediate (with removed intron 2) between N and S cells suggests higher splicing eciency of intron 2 and/or increased stability of this RNA species in N cells. The latter ratio (3.4) is nearly identical to the 3.8-fold ratio for the mature cytoplasmic N-myc mRNA measured previously for this line pair (Spengler et al., 1997) . Thus, dierential processing eciency and/or stability of nuclear N-myc pre-mRNA species could account for the dierences seen in the steadystate levels of N-myc mRNA between N and S cells.
HuD binding to N-myc mRNA
Of the three Hu antigens, only HuD speci®cally binds long N-myc 3'-UTR probes (5400 nt). Our results con®rm the lack of binding of Hel-N1 to a 623 nt Nmyc 3'-UTR probe reported by Levine and coworkers (1993) , but contrast with a more recent ®nding that Hel-N1 binds short (18 ± 22 nt) U-rich sequences from the N-myc 3'-UTR . Studies on binding of the homologous protein Sex-lethal suggest one reason for this apparent discrepancy. Sex-lethal protein binds not only U-rich sequences but also a second type of site determined by RNA secondary structure (Wang et al., 1997) . In addition, RNA secondary structure may mask or expose certain AU-rich sequence targets. Therefore, the binding of proteins to long RNA probes may dier from that to short probes.
Potential nuclear function for HuD
Our observation that HuD binds not only exonic but also intronic N-myc RNA elements supports a hypothetical nuclear function for this protein. The Nmyc intron 1 and 3'-UTR sequences to which HuD speci®cally binds have been identi®ed as potential cisacting regulators of the cell-speci®c expression of this proto-oncogene (Babiss and Friedman, 1990; Sivak et al., 1997) . The ®rst cis-acting element identi®ed was localized to a 600 nt fragment within the N-myc 3'-UTR. When the fragment was inserted downstream of E1A promoter, it decreased the level of E1A mRNA in virus-infected non-neuronal HeLa cells, whereas it maintained E1A expression in G401 Wilms' tumor cells and in SK-N-MC neuroepithelioma cells (Babiss and Friedman, 1990) . The second element identi®ed was localized to a 116 nt fragment within the mouse Nmyc intron 1. This fragment directed expression of a reporter gene only in cells in which the endogenous Nmyc gene was active (Sivak et al., 1997) . Therefore, by binding these two cis-acting elements, HuD may contribute to lineage-speci®c N-myc expression.
The results from our transfection experiments with human NB cells support the hypothesis that HuD is a post-transcriptional regulator of N-myc expression. Changes in N-myc expression are directly proportional to changes in HuD expression in both sense HuD-and antisense HuD-transfected N cells. The regulation of N-myc expression by HuD is most probably direct, since the increase in N-myc protein level is seen within 24 h of transfection of LA1-55n cells with a HuDexpression construct.
Possible roles of HuD in the regulation of nuclear processing/stability of N-myc pre-mRNA
The binding of HuD to N-myc 3'-UTR sequences may contribute to ecient 3' cleavage/polyadenylation of the nascent transcript by altering RNA conformation or by facilitating binding or stabilization of the polyadenylation machinery. This proposed mechanism is similar to the regulation of the 3' end processing of some viral pre-mRNAs and Drosophila hsp70 transcripts by their 3'-UTR sequences (Berger and Meselson, 1994; Graveley et al., 1996) .
The binding of HuD to intron 1 sequences may increase eciency of 3' end processing and/or splicing of intron 2. Similarly, an intron sequence of calcitonin/ calcitonin gene-related peptide RNA activates cleavage/polyadenylation of its own pre-mRNA via interaction with U1 snRNP, a complex associated with functional 5' splice sites (Lou et al., 1996) .
Finally, HuD may stabilize N-myc pre-mRNA. Naturally occurring antisense N-myc transcripts which extend across the exon 1/intron 1 boundary have been proposed to form double stranded RNA with nascent N-myc transcripts and lead to their degradation (Krystal et al., 1990) . Such degradation may occur in S cells, resulting in lower N-myc pre-mRNA and mRNA steady-state levels. In N cells, binding of HuD to intron 1 would prevent formation of RNA-RNA duplexes.
Conclusion
Our ®ndings suggest that HuD is involved in the nuclear processing/stability of N-myc pre-mRNA in malignant neuroblasts. The identi®cation of a nuclear post-transcriptional control mechanism for N-myc expression is novel and of importance both embryologically and clinically. The suggested co-expression of HuD and N-myc during initial stages of neurogenesis might be instrumental for normal development of the nervous system. However, in NBs and other neuroendocrine tumors with ampli®ed N-myc genes, the presence of HuD may contribute to increased N-myc expression levels and, thereby, to increased malignancy.
Materials and methods
Tissue culture and cell lines NB cell lines are maintained in a 1 : 1 mixture of Eagle's Minimum Essential Medium with non-essential amino acids and Ham's Nutrient Mixture F12 (Life Technologies, Gaithersburg, MD, USA), supplemented with 15% fetal bovine serum (HyClone, Logan, UT, USA) and no antibiotics. The human NB lines used in this study have been previously described (Biedler et al., 1978; Seeger et al., 1977; Spengler et al., 1997) .
Western blot analysis
Cells were lysed by published procedures (Ikegaki et al., 1986) and 50 mg of total protein was separated on SDSpolyacrylamide gels, transferred to nitrocellulose ®lters (Schleicher and Schuell, Keene, NH, USA), and immunostained (Ciccarone et al., 1989) . The antibodies used were anti-actin antibody C4 (Boehringer Mannheim, Indianapolis, IN, USA), anti-N-myc antibody NCM II 100 (Oncogene Science, Uniondale, NY, USA), human anti-Hu sera (kindly provided by Dr JB Posner, Memorial Sloan-Kettering Cancer Center, New York, NY, USA), anti-vimentin serum crossreacting with nuclear lamins (Biomeda, Foster City, CA, USA), anti-secretogranin II antibody (kindly provided by Dr JG Scammell, University of South Alabama, Mobile, AL, USA), and anti-neuro®lament 150 kD antibody (Boehringer Mannheim, Indianapolis, IN, USA). Signal was detected by chemiluminescence (Pierce, Rockford, IL, USA).
Cell fractionation
LA1-55n cells were lysed with NP-40 buer (Favaloro et al., 1980) and centrifuged at 2500 g for 5 min. The supernate was used as cytoplasmic fraction. The nuclear pellet was washed three times with lysis buer, centrifuged, and lysed with SDScontaining Tris buer (Ikegaki et al., 1986) . Nuclear and cytoplasmic fractions were analysed by Western blot analysis.
Northern blot analysis
Total RNA was isolated by the procedure of Chomczynski and Sacchi (1987) . Poly(A) + RNA was isolated with a kit from Collaborative Research (Boston, MA, USA). Nuclear RNA was isolated by the method of Chomczynski and Sacchi (1987) from nuclear pellets prepared as described above with NP-40 buer. Probes for Hu mRNAs were derived by PCR from sequences encoding the stringer region. The PCR primers were published previously (Manley et al., 1995) . The N-myc probes to intron 1 and 2, as well as to exon 3, were derived from vectors described below. Signal for 18S and/or g-actin RNA (Erba et al., 1986 ) was used to control for loading dierences. Probes were labeled with the Prime-agene labeling kit (Promega, Madison, WI, USA) using a-32 PdCTP (Dupont NEN, Boston, MA, USA).
Expression of fusion proteins
pET-21b(+)HuD has been described (Manley et al., 1995) . The cDNAs encoding the open reading frames of HuC and Hel-N1 were subcloned from their pCMV constructs (Manley et al., 1995) by PCR using speci®c primers with restriction sites at their 5' ends (5'Hel-N1: CGGACGGATCCGGAAA-CACAACTGTCTAATG, 3'Hel-N1: CTGCGCTCGAGT-TAGGCTTTGTGGTTTTG; 5'HuC: CATATGGATCCT-GAGTCTCAGGTGGGG GGG, 3'HuC: GTGCCAAGC-TTCGC CTTGTGCTGTTTGCT). The PCR products were restriction enzyme-digested and subcloned into pET-21b(+) vector (Novagen, Madison, WI, USA). BL21(DE3)pLysS cells were transformed with these constructs and production of recombinant proteins was induced according to the protocol of the manufacturer (Novagen, Madison, WI, USA). Bacterial lysates were obtained as previously described (Levine et al., 1993) .
Plasmids and mRNA transcripts
Plasmids pcRII-NM (873 nt of N-myc 3'-UTR), pCRII-FNM (491 nt at the 5' end of N-myc 3'-UTR), pCRII-SNM (399 nt at the 3' end of N-myc 3'-UTR), and pCRScript-NMin1 (417 nt of N-myc intron 1) were constructed by cloning PCR products into pCRII (Invitrogen, Carlsbad, CA, USA) or pCRScript (Stratagene, La Jolla, CA, USA) vector. The primers were 5'NM and 5'FNM: GACTTGCTA-GACGCTTCTCA, 3'NM and 3'SNM: GTGCTATAA-GATGCAGCAC, 3'FNM: CTTCCAGTCTAATACTGG-CC, 5'SNM: GCCAGTATTAGACTGGAAG, 5'NMin1: GTTCTTCTCCAAAGGGTGCCCCTG, and 3'NMin1: TGCAACCTCAGGAGTGCAAATGATAG. PCR templates were an N-myc cDNA clone isolated from a cDNA library of NB cell line KCN-69n, and genomic DNA from LA1-55n NB cells. Plasmid pcRII-CEA (203 nt of the CEA gene) was kindly provided by Dr M Bordonaro (Monte®ore Medical Center, Bronx, NY, USA) and pcRII-ACTN4 (594 nt of the 3'-UTR of the ACTN4 gene) was kindly provided by Dr S Nikolopoulos (Fordham University, Bronx, NY, USA). Radiolabeled transcripts (Epicentre Technologies, Madison, WI, USA), 2 ± 8610 8 c.p.m./mg, were puri®ed with G-50 Sephadex columns or gel puri®ed.
Gel mobility shift assay
Radiolabeled RNA probes were incubated with bacterial lysates in RNA binding buer (Chen et al., 1995) at 208C for 10 min. For competition experiments, labeled RNA probe and unlabeled competitor RNA were incubated together for 5 min at 208C before addition of bacterial lysate. Binding reactions were resolved by electrophoresis through a 3.2% non-denaturing polyacrylamide gel with Tris-glycine buer.
Transfections
The pcDNA3HuD vector used for sense transfections was kindly provided by Dr M Rosenfeld (Memorial SloanKettering Cancer Center, New York, NY, USA). The construct for antisense transfections was prepared by cloning a PCR product encoding part of the HuD stringer region (748 ± 945 nt) (Szabo et al., 1991) in an antisense orientation into a pBactNeo vector (Reis et al., 1992) . Cells were transfected using Lipofectamine (Life Technologies, Gaithersburg, MD, USA). Transiently transfected cells were assayed after 24 h. Stable transfectants were selected in medium with G418 (Life Technologies, Gaithersburg, MD, USA) and resistant clones were obtained by the limiting dilution method.
